Mesoporous Silica-based Nanomaterials and Biomedical Applications - Part A
Nonfiction, Science & Nature, Science, Biological Sciences, Biophysics, Biochemistry
| Author: | Fuyuhiko Tamanoi | ISBN: | 9780128155219 |
| Publisher: | Elsevier Science | Publication: | September 20, 2018 |
| Imprint: | Academic Press | Language: | English |
| Author: | Fuyuhiko Tamanoi |
| ISBN: | 9780128155219 |
| Publisher: | Elsevier Science |
| Publication: | September 20, 2018 |
| Imprint: | Academic Press |
| Language: | English |
Cancer Therapy and Diagnosis, Part A, Volume 43 in The Enzymes series, highlights new advances in the field, with this new volume presenting interesting chapters on Mesoporous silica nanoparticle synthesis, Periodic mesoporous organosilica, Nanovalves and other nanomachine-equipped nanoparticles and controlled release, Two-photon light control and photodynamic therapy, Biodegradable PMO nanoparticles, Cationic mesoporous silica and protein delivery, Drug loading, stimuli-responsive delivery and cancer treatment, Animal models and cancer therapy, siRNA delivery and TWIST shutdown for ovarian cancer treatment, and TBC (mesoporous silica nanoparticles and cancer therapy or biodistribution of MSN).
- Provides the authority and expertise of leading contributors from an international board of authors
- Presents the latest release in The Enzymes series
- Updated release includes the latest information on Cancer Therapy and Diagnosis
Cancer Therapy and Diagnosis, Part A, Volume 43 in The Enzymes series, highlights new advances in the field, with this new volume presenting interesting chapters on Mesoporous silica nanoparticle synthesis, Periodic mesoporous organosilica, Nanovalves and other nanomachine-equipped nanoparticles and controlled release, Two-photon light control and photodynamic therapy, Biodegradable PMO nanoparticles, Cationic mesoporous silica and protein delivery, Drug loading, stimuli-responsive delivery and cancer treatment, Animal models and cancer therapy, siRNA delivery and TWIST shutdown for ovarian cancer treatment, and TBC (mesoporous silica nanoparticles and cancer therapy or biodistribution of MSN).
- Provides the authority and expertise of leading contributors from an international board of authors
- Presents the latest release in The Enzymes series
- Updated release includes the latest information on Cancer Therapy and Diagnosis
